Stockreport

Atalanta Therapeutics Publishes Preclinical Data Supporting Investigational RNAi Therapy for KCNT1-Related Epilepsy [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF – Data support continued advancement to the clinic, with IND submission planned in 2025 BOSTON, April 08, 2025 BUSINESS WIRE Atalanta Therapeutics , a biotechnology c [Read more]